title: Tardive Dyskinesia: analysis of outpatients with schizophrenia from Africa and the Middle East, Asia, Central and Eastern Europe, and Latin America.
abstract: The point prevalence of Tardive Dyskinesia (TD) in schizophrenia outpatients (n=6981) participating in a study of health outcomes was 8.9%. Duration of diagnosis, age, and prior use of typical antipsychotics were diagnostic indicators of TD in this population, with male sex further increasing risk. This study provides new data in a non-Western population with a unique regional geography comparison.
authors.affiliation: Department of General Psychiatry, Medical University of Vienna, Wahringer Gurtel 18-20, A-1090 Vienna, Austria. sci-genpsy@meduniwien.ac.at
authors.forename: Siegfried
authors.initials: S
authors.lastname: Kasper
authors.forename: Amanda J
authors.initials: AJ
authors.lastname: Lowry
authors.forename: Andrew
authors.initials: A
authors.lastname: Hodge
authors.forename: Istvan
authors.initials: I
authors.lastname: Bitter
authors.forename: Martin
authors.initials: M
authors.lastname: Dossenbach
mesh_terms: D000328:Adult; D000349:Africa; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001208:Asia; D003431:Cross-Cultural Comparison; D003430:Cross-Sectional Studies; D004409:Dyskinesia, Drug-Induced / Q000453:epidemiology*; D005061:Europe, Eastern; D005260:Female; D006801:Humans; D007843:Latin America; D008297:Male; D008875:Middle Aged; D008877:Middle East; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents